| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Ben May Institute for Cancer Research, Department of Biochemistry and Molecular Biology, and Tang Center for Herbal Medicine Research, University of Chicago, Chicago, Illinois 60637
Address all correspondence and requests for reprints to: Dr. S. Liao, Ben May Institute for Cancer Research, University of Chicago, 5841 South Maryland Avenue, MC 6027, Chicago, Illinois 60637. E-mail: sliao{at}huggins.bsd.uchicago.edu
Green tea polyphenols, especially the catechin, (-)-epigallocatechin gallate (EGCG), have been proposed as a cancer chemopreventative based on a variety of laboratory studies. For clear assessment of the possible physiological effects of green tea consumption, we injected pure green tea catechins ip into rats and studied their acute effects on endocrine systems. We found that EGCG, but not related catechins, significantly reduced food intake; body weight; blood levels of testosterone, estradiol, leptin, insulin, insulin-like growth factor I, LH, glucose, cholesterol, and triglyceride; as well as growth of the prostate, uterus, and ovary. Similar effects were observed in lean and obese male Zucker rats, suggesting that the effect of EGCG was independent of an intact leptin receptor. EGCG may interact specifically with a component of a leptin-independent appetite control pathway. Endocrine changes induced by parenteral administration of EGCG may relate to the observed growth inhibition and regression of human prostate and breast tumors in athymic mice treated with EGCG as well as play a role in the mechanism by which EGCG inhibits cancer initiation and promotion in various animal models of cancer.
This article has been cited by other articles:
 |
|
 |
|
  K. S. Stote and D. J. Baer Tea Consumption May Improve Biomarkers of Insulin Sensitivity and Risk Factors for Diabetes J. Nutr., August 1, 2008; 138(8): 1584S - 1588S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Laschke, C. Schwender, C. Scheuer, B. Vollmar, and M. D. Menger Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo Hum. Reprod., July 4, 2008; (2008) den245v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. F. Collins, H.-Y. Liu, J. Pi, Z. Liu, M. J. Quon, and W. Cao Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5'-AMP-activated Protein Kinase J. Biol. Chem., October 12, 2007; 282(41): 30143 - 30149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wolfram Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health J. Am. Coll. Nutr., August 1, 2007; 26(4): 373S - 388S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-a Kim, G. Formoso, Y. Li, M. A. Potenza, F. L. Marasciulo, M. Montagnani, and M. J. Quon Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn J. Biol. Chem., May 4, 2007; 282(18): 13736 - 13745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Potenza, F. L. Marasciulo, M. Tarquinio, E. Tiravanti, G. Colantuono, A. Federici, J.-a Kim, M. J. Quon, and M. Montagnani EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1378 - E1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Cho, P. J. Park, H. J. Shin, Y.-K. Kim, D. W. Shin, E. S. Shin, H. H. Lee, B. G. Lee, J.-H. Baik, and T. R. Lee (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1166 - E1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Diepvens, K. R. Westerterp, and M. S. Westerterp-Plantenga Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R77 - R85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wolfram, D. Raederstorff, M. Preller, Y. Wang, S. R. Teixeira, C. Riegger, and P. Weber Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents J. Nutr., October 1, 2006; 136(10): 2512 - 2518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Su, L.-M. Hung, and J.-K. Chen Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1339 - E1346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Liu, Y.-H. Chen, P.-F. Hung, and Y.-H. Kao Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E273 - E281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study Cancer Res., January 15, 2006; 66(2): 1234 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C.W. Chan, M. W.L. Koo, E. H.Y. Ng, O.-S. Tang, W. S.B. Yeung, and P.-C. Ho Effects of Chinese Green Tea on Weight, and Hormonal and Biochemical Profiles in Obese Patients With Polycystic Ovary Syndrome--A Randomized Placebo-Controlled Trial Reproductive Sciences, January 1, 2006; 13(1): 63 - 68. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Li, P. Stillemark-Billton, C. Beck, P. Bostrom, L. Andersson, M. Rutberg, J. Ericsson, B. Magnusson, D. Marchesan, A. Ljungberg, et al. Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL J. Lipid Res., January 1, 2006; 47(1): 67 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Wu, K. Arakawa, F. Z. Stanczyk, D. Van Den Berg, W.-P. Koh, and M. C. Yu Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore Carcinogenesis, May 1, 2005; 26(5): 976 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-F. Hung, B.-T. Wu, H.-C. Chen, Y.-H. Chen, C.-L. Chen, M.-H. Wu, H.-C. Liu, M.-J. Lee, and Y.-H. Kao Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1094 - C1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-P. St-Onge Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 7 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pinent, M. Blay, M. C. Blade, M. J. Salvado, L. Arola, and A. Ardevol Grape Seed-Derived Procyanidins Have an Antihyperglycemic Effect in Streptozotocin-Induced Diabetic Rats and Insulinomimetic Activity in Insulin-Sensitive Cell Lines Endocrinology, November 1, 2004; 145(11): 4985 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Caporali, P. Davalli, S. Astancolle, D. D'Arca, M. Brausi, S. Bettuzzi, and A. Corti The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression Carcinogenesis, November 1, 2004; 25(11): 2217 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Goodin and R. J. Rosengren Epigallocatechin Gallate Modulates CYP450 Isoforms in the Female Swiss-Webster Mouse Toxicol. Sci., December 1, 2003; 76(2): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chen and L. Zhang The Antioxidant (-)-Epigallocatechin-3-gallate Inhibits Rat Hepatic Stellate Cell Proliferation in Vitro by Blocking the Tyrosine Phosphorylation and Reducing the Gene Expression of Platelet-derived Growth Factor-{beta} Receptor J. Biol. Chem., June 20, 2003; 278(26): 23381 - 23389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Goodin, K. C. Fertuck, T. R. Zacharewski, and R. J. Rosengren Estrogen Receptor-Mediated Actions of Polyphenolic Catechins in Vivo and in Vitro Toxicol. Sci., October 1, 2002; 69(2): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Waltner-Law, X. L. Wang, B. K. Law, R. K. Hall, M. Nawano, and D. K. Granner Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production J. Biol. Chem., September 13, 2002; 277(38): 34933 - 34940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yoshikawa, H. Shimoda, N. Nishida, M. Takada, and H. Matsuda Salacia reticulata and Its Polyphenolic Constituents with Lipase Inhibitory and Lipolytic Activities Have Mild Antiobesity Effects in Rats J. Nutr., July 1, 2002; 132(7): 1819 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rumpler, J. Seale, B. Clevidence, J. Judd, E. Wiley, S. Yamamoto, T. Komatsu, T. Sawaki, Y. Ishikura, and K. Hosoda Oolong Tea Increases Metabolic Rate and Fat Oxidation in Men J. Nutr., November 1, 2001; 131(11): 2848 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-h. Kao, R. A Hiipakka, and S. Liao Modulation of obesity by a green tea catechin Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1232 - 1233. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
